MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
12.77
+0.21 (1.67%)
At close: Nov 14, 2025, 4:00 PM EST
12.68
-0.09 (-0.70%)
After-hours: Nov 14, 2025, 7:53 PM EST
MLTX Market Cap
MLTX has a market cap or net worth of $911.44 million as of November 14, 2025. Its market cap has decreased by -69.16% in one year.
Market Cap
911.44M
Enterprise Value
606.69M
1-Year Change
-69.16%
Ranking
Category
Stock Price
$12.77
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $911.44M, an increase of 25,231.31%. That is a compound annual growth rate of 337.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 911.44M | -73.31% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 915.57B |
| Johnson & Johnson | 470.01B |
| AbbVie | 408.64B |
| UnitedHealth Group | 292.32B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 231.90B |
| Abbott Laboratories | 225.33B |